Innovation 

Platform

Tavo Select™
Tavo Select™
Tavo Precise™
Tavo Precise™
Tavo ELITE™
Tavo ELITE™

HOW OUR TECHNOLOGY TARGETS TUMORS

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs. Our company management and advisors consist of veteran pharmaceutical executives with multiple prior successes in the development and commercialization of many blockbuster biologics currently in the market. Tavotek has 3 diverse R&D platform for biologics: TavoSelect™ (Phage Display Library), TavoPrecise™ (Tissue-specific biologics engineering platform), and TavoELITE™ (Intracellular Undruggable Target platform). Along with these platforms, Tavotek has a rich and diverse pipeline of product candidates focused on cancers, autoimmune conditions, and infectious diseases in various stages of development. We are globally connected with operations in Asia and North America. Our development strategy includes organic growth, biopharma collaboration, and potential clinical stage asset licensing.

COMPANY

2022

2013
2019
Established in
50
11 +
Assets in Different Stages
10
25 +
Years Ex-Big Pharma Executives with Ample Experiences
2013
60 +
Top-Notch and Well-Trained Talents

LATEST

NEWS

10-28 2022

Tavotek Biotherapeutics Announces FDA Clearance of FIH Clinical Trial for TAVO412

(LOWER GWYNEDD, Pennsylvania, October 28, 2022) Tavotek Biotherapeutics announced today that it has received clearance of its Investigational New Drug....

Read More
拓创科技
Tavotek Pivotal Asset Tavo412 Presented at 2022 AAPS National Biotech Conference
(LOWER GWYNEDD, Pennsylvania, May 12, 2022)  Tavotek Biotherapeutics, a fast-growing biopharmaceutical company, announced that its pivotal oncology as....
2022-05-12
拓创科技
Tavotek Biotherapeutics Announces Formation and Member of Scientific Advisory Board
(LOWER GWYNEDD, Pennsylvania, April 25, 2022)  Tavotek Biotherapeutics, a fast-growing biopharmaceutical company focusing on discovering and developin....
2022-04-25
imgboxbg

TavoSELECT™ Phage Library

TavoSELECT™ provides access to antibodies or biomolecules that target membrane proteins, intracellular proteins, or antigens that are more difficult to target due to the blood-brain barrier, etc.

imgboxbg

TavoPRECISE™ Platform

TavoPRECISE™ is a Fit-for-Purpose monoclonal antibody and multi-specific biologics development.

imgboxbg

TavoELITE™ Platform

TavoELITE™, a novel platform that goes after intracellular targets for the treatment of cancer and other diseases., a novel platform that goes after intracellular targets for the treatment of cancer and other diseases.

 

727 Norristown Road, 3 Spring House Innovation Park Suite 101, Lower Gwynedd, Pennsylvania 19002

China. Suzhou. Suzhou Industrial Park. Unit 405, Building C2, No. 218, Xinghu Street

© 2022 Tavotek Biotherapeutics All rights reserved.   (267) 405-9426

© 2022 Tavotek Biotherapeutics All rights reserved.(267) 405-9426